(INMD) InMode - Ratings and Ratios
Exchange: NASDAQ • Country: Israel • Currency: USD • Type: Common Stock • ISIN: IL0011595993
INMD: Radiofrequency, Body Contouring, Skin Tightening, Fat Reduction
InMode Ltd (NASDAQ:INMD) is a global leader in the development of innovative, minimally invasive and non-invasive aesthetic medical solutions. The company specializes in proprietary radiofrequency (RF) technologies, including RF-assisted lipolysis and deep subdermal fractional RF, to address a wide range of aesthetic and wellness needs. Its product portfolio includes systems for liposuction with simultaneous skin tightening, body and facial contouring, ablative skin rejuvenation, and womens health applications. In addition, InMode offers non-invasive solutions for permanent hair reduction, facial rejuvenation, wrinkle reduction, cellulite treatment, and vascular lesion removal. The company also innovates in hands-free technologies for skin tightening, fat reduction, and muscle stimulation, catering to both aesthetic and therapeutic markets.
Headquartered in Yokneam, Israel, InMode operates a global distribution network spanning the U.S., Canada, Europe, Asia, and Australia. The company, formerly known as Invasix Ltd., was renamed InMode Ltd. in 2017 and has established itself as a key player in the medical aesthetics industry. With a market capitalization of $895.51 million and a trailing P/E of 6.59, InMode demonstrates strong profitability with an ROE of 28.38%. The stock currently trades at $14.57, below its SMA 20 ($15.04) and SMA 50 ($17.13), signaling a near-term downtrend. The ATR of 0.93 reflects moderate volatility. Looking ahead, InModes focus on R&D and expanding its product portfolio positions it for growth in a competitive market.
Additional Sources for INMD Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
INMD Stock Overview
Market Cap in USD | 896m |
Sector | Healthcare |
Industry | Medical Devices |
GiC Sub-Industry | Health Care Equipment |
IPO / Inception | 2019-08-08 |
INMD Stock Ratings
Growth Rating | -13.2 |
Fundamental | 56.6 |
Dividend Rating | 0.0 |
Rel. Strength | -19 |
Analysts | 3.71/5 |
Fair Price Momentum | 12.39 USD |
Fair Price DCF | 26.35 USD |
INMD Dividends
No Dividends PaidINMD Growth Ratios
Growth Correlation 3m | -86.9% |
Growth Correlation 12m | -16.3% |
Growth Correlation 5y | -33.6% |
CAGR 5y | 0.20% |
CAGR/Max DD 5y | 0.00 |
Sharpe Ratio 12m | 1.08 |
Alpha | -33.27 |
Beta | 1.060 |
Volatility | 65.15% |
Current Volume | 1197.2k |
Average Volume 20d | 1242k |
As of May 09, 2025, the stock is trading at USD 14.23 with a total of 1,197,173 shares traded.
Over the past week, the price has changed by -3.20%, over one month by -1.73%, over three months by -23.25% and over the past year by -22.24%.
Partly, yes. Based on ValueRay Fundamental Analyses, InMode (NASDAQ:INMD) is currently (May 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 56.55 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of INMD as of May 2025 is 12.39. This means that INMD is currently overvalued and has a potential downside of -12.93%.
InMode has received a consensus analysts rating of 3.71. Therefor, it is recommend to hold INMD.
- Strong Buy: 2
- Buy: 1
- Hold: 4
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, INMD InMode will be worth about 14.1 in May 2026. The stock is currently trading at 14.23. This means that the stock has a potential downside of -0.77%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 17.3 | 21.2% |
Analysts Target Price | 20.8 | 46.4% |
ValueRay Target Price | 14.1 | -0.8% |